Methotrexate Maintenance After Initiation of Biological or Targeted Synthetic DMARDs in Rheumatoid Arthritis: Results from the 2-Year Longitudinal Prospective Non-interventional STRATEGE2 Study

Abstract Introduction The primary objective was to describe the therapeutic approach to methotrexate (MTX) use at the initiation of the first biologic or targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) in the treatment of rheumatoid arthritis (RA). Secondary objectives included c...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Cécile Gaujoux-Viala, Emmanuelle Dernis, Eric Senbel, Hélène Herman-Demars, Jennifer Becker, René-Marc Flipo
Format:	Artigo
Jezik:	Inglês
Izdano:	Adis, Springer Healthcare 2025-12-01
Serija:	Rheumatology and Therapy
Teme:	DMARDs Methotrexate Rheumatoid arthritis Treat-to-target
Online dostop:	https://doi.org/10.1007/s40744-025-00806-1
Oznake:	Označite Brez oznak, prvi označite!